1-2 of 2
Meletius Dimopoulos
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Lenalidomide (L) in Combination with Dexamethasone (D) Significantly Improves Time to Progression (TTP) in Non-Stem Cell Transplant Patients (pts) with Relapsed or Refractory (rel/ref) Multiple Myeloma (MM): Analysis from MM-009 and MM-010 Randomized Phase III Clinical Trials.

Asher Alban Chanan-Khan, MD, Zhinuan Yu, PhD, Donna Weber, MD, Christine Chen, MD, Ruben Niesvizky, MD, Andrew Spencer, MD, Michel Attal, MD, Andrew Belch, MD, Miles Prince, MD, Marta Olesnyckyj, Robert Knight, MD, Jerome Zeldis, MD, Meletius Dimopoulos, MD
Journal: Blood
Blood (2006) 108 (11): 3554.
https://doi.org/10.1182/blood.V108.11.3554.3554
Published: 2006
Journal Articles

Lenalidomide (L) in Combination with Dexamethasone (D) Improves Survival and Time to Progression in Elderly Patients (pts) with Relapsed or Refractory (rel/ref) Multiple Myeloma (MM).

Asher Alban Chanan-Khan, MD, Donna Weber, Meletius Dimopoulos, Christine Chen, Reuben Niesvizky, Michael Wang, Andrew Belch, Michel Attal, Andrew Spencer, Miles Prince, Marta Olesnyckyj, Jerome Zeldis, Zhinuan Yu, Robert Knight
Journal: Blood
Blood (2006) 108 (11): 3551.
https://doi.org/10.1182/blood.V108.11.3551.3551
Published: 2006